Ocugen Inc. (NASDAQ: OCGN), Provention Bio Inc. (NASDAQ: PRVB), Contextlogic Inc. (NASDAQ: WISH), and Acasti Pharma Inc. (NASDAQ: ACST) are facing an investigation from various law firms on behalf of shareholders over potential securities laws violation. Contextlogic under probe Levi & Korsinsjy LLP is investigating Contextlogic on behalf of investors […]
Tag: Acasti Pharma Inc (NASDAQ: ACST)
Acasti Pharma Inc (NASDAQ: ACST) Conveys Apprise of Plans to Acquire Grace Therapeutics
Acasti Pharma Inc (NASDAQ: ACST) today delivered an apprise on its tactics to obtain Grace. As part of Acasti’s official procedure to inspect and assess various planned replacements to improve bondholder worth, the administration and the board assessed many corporations and steered an all-embracing and detailed due assiduousness procedure on […]
Acasti Pharma Inc (NASDAQ: ACST) Moves Into A Definitive Agreement To Buy Off Grace Therapeutics
The stock of Acasti Pharma Inc (NASDAQ: ACST) rose by a margin of 6.8% to finally settle at $0.57.This company is excited to pronounce its entry into a definitive agreement, a deal that will see it win Grace Therapeutics to its side. Grace Therapeutics has been focusing on developing products […]